Quick Answer
Pulmonx Corp reported Total Revenue of $90.50 million for fiscal year 2025.
Pulmonx Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $90.50M +8.0% |
$83.79M +22.0% |
$68.67M +28.0% |
$53.66M +10.8% |
$48.42M +47.9% |
$32.73M +0.4% |
| Revenue (ASC 606) | $90.50M +8.0% |
$83.79M +22.0% |
$68.67M +28.0% |
$53.66M +10.8% |
$48.42M +47.9% |
$32.73M +0.4% |
| Net Income | -$54.00M +4.2% |
-$56.39M +7.3% |
-$60.84M -3.3% |
-$58.92M -21.1% |
-$48.66M -51.0% |
-$32.23M -55.7% |
| Diluted EPS | -$1.33 +7.6% |
-$1.44 +10.0% |
-$1.60 -0.6% |
-$1.59 -17.8% |
-$1.35 +57.3% |
-$3.16 |
| Total Assets | $129.29M -20.6% |
$162.85M -8.4% |
$177.78M -8.2% |
$193.68M -17.6% |
$235.17M -10.8% |
$263.71M +392.6% |
| Cash and Equivalents | $69.75M -1.6% |
$70.91M -15.1% |
$83.55M -17.9% |
$101.74M -31.5% |
$148.48M -35.9% |
$231.56M +1468.1% |
| Long-Term Debt | $36.99M +8.8% |
$34.00M -3.1% |
$35.09M +103.6% |
$17.23M | — | — |
| Stockholders Equity | $54.12M -36.9% |
$85.81M -27.5% |
$118.31M -23.2% |
$154.01M -20.3% |
$193.24M -14.5% |
$226.13M +220.7% |
| R&D Expense | $19.49M +10.9% |
$17.57M -2.8% |
$18.08M +17.4% |
$15.40M +17.9% |
$13.06M +75.1% |
$7.46M +23.3% |
| Operating Income | -$53.66M +7.0% |
-$57.70M +6.8% |
-$61.94M -5.6% |
-$58.64M -24.0% |
-$47.30M -46.3% |
-$32.33M -81.3% |
| Gross Profit | $67.14M +8.3% |
$62.00M +22.2% |
$50.75M +27.3% |
$39.87M +11.9% |
$35.63M +68.1% |
$21.20M -5.4% |
| Shares Outstanding | 41.67M +4.7% |
39.79M +3.3% |
38.52M +2.6% |
37.56M +1.7% |
36.93M +3.5% |
35.69M +1599.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $21.50M | +5.5% | -9.9% |
| Revenue (ASC 606) | September 30, 2025 | $21.50M | +5.5% | -9.9% |
| Net Income | September 30, 2025 | -$13.96M | +1.3% | +8.0% |
| Diluted EPS | September 30, 2025 | -$0.34 | +5.6% | +10.5% |
| Total Assets | September 30, 2025 | $138.28M | -17.4% | -6.1% |
| Cash and Equivalents | September 30, 2025 | $76.55M | +20.9% | +1.4% |
| Long-Term Debt | September 30, 2025 | $37.02M | -0.3% | +0.0% |
| Stockholders Equity | September 30, 2025 | $60.03M | -36.1% | -13.1% |
| R&D Expense | September 30, 2025 | $4.85M | +29.4% | -8.7% |
| Operating Income | September 30, 2025 | -$14.39M | -1.9% | +2.8% |
| Gross Profit | September 30, 2025 | $16.05M | +6.8% | -6.7% |
| Shares Outstanding | September 30, 2025 | 41.25M | +4.5% | +1.2% |
- Pulmonx Corp reported Total Revenue of $90.50 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +8.0% in Total Revenue compared to the prior fiscal year.
- Pulmonx Corp reported Revenue (ASC 606) of $90.50 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +8.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Pulmonx Corp reported Net Income of -$54.00 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +4.2% in Net Income compared to the prior fiscal year.
- Pulmonx Corp reported Diluted EPS of $1.33 per share (loss) for fiscal year 2025.
- Pulmonx Corp showed an increase of +7.6% in Diluted EPS compared to the prior fiscal year.
- Pulmonx Corp reported Total Assets of $129.29 million for fiscal year 2025.
- Pulmonx Corp showed a decrease of -20.6% in Total Assets compared to the prior fiscal year.
- Pulmonx Corp reported Cash and Equivalents of $69.75 million for fiscal year 2025.
- Pulmonx Corp showed a decrease of -1.6% in Cash and Equivalents compared to the prior fiscal year.
- Pulmonx Corp reported Long-Term Debt of $36.99 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +8.8% in Long-Term Debt compared to the prior fiscal year.
- Pulmonx Corp reported Stockholders Equity of $54.12 million for fiscal year 2025.
- Pulmonx Corp showed a decrease of -36.9% in Stockholders Equity compared to the prior fiscal year.
- Pulmonx Corp reported R&D Expense of $19.49 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +10.9% in R&D Expense compared to the prior fiscal year.
- Pulmonx Corp reported Operating Income of -$53.66 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +7.0% in Operating Income compared to the prior fiscal year.
- Pulmonx Corp reported Gross Profit of $67.14 million for fiscal year 2025.
- Pulmonx Corp showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- Pulmonx Corp reported Shares Outstanding of 41.67 million shares for fiscal year 2025.
- Pulmonx Corp showed an increase of +4.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: